Nicholas Muzyczka
#153,134
Most Influential Person Now
Nicholas Muzyczka's AcademicInfluence.com Rankings
Nicholas Muzyczkaengineering Degrees
Engineering
#6273
World Rank
#7589
Historical Rank
Bioengineering
#66
World Rank
#68
Historical Rank
Applied Physics
#1976
World Rank
#2011
Historical Rank

Download Badge
Engineering
Nicholas Muzyczka's Degrees
- Bachelors Bioengineering University of California, Berkeley
- PhD Bioengineering University of California, Berkeley
Why Is Nicholas Muzyczka Influential?
(Suggest an Edit or Addition)Nicholas Muzyczka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield (1999) (1247)
- Use of adeno-associated virus as a general transduction vector for mammalian cells. (1992) (771)
- Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. (2004) (725)
- Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System (2002) (682)
- A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells (1996) (648)
- Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. (2002) (553)
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses (2008) (511)
- The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity (1990) (470)
- Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. (1984) (438)
- Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. (1982) (422)
- Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. (1997) (399)
- Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism (2000) (383)
- Adeno-associated virus general transduction vectors: analysis of proviral structures (1988) (367)
- AAV-Mediated Gene Therapy for Research and Therapeutic Purposes. (2014) (344)
- Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding (2003) (332)
- Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. (1998) (305)
- Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein: A new primate model of Parkinson's disease (2003) (305)
- Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants (1984) (294)
- Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV (1983) (293)
- Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters (1997) (283)
- The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease (2008) (280)
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors (2001) (267)
- Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78 (2010) (267)
- Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors (1998) (255)
- Site-specific integration by adeno-associated virus. (1990) (244)
- Continuous Low-Level Glial Cell Line-Derived Neurotrophic Factor Delivery Using Recombinant Adeno-Associated Viral Vectors Provides Neuroprotection and Induces Behavioral Recovery in a Primate Model of Parkinson's Disease (2005) (231)
- Studies on the biochemical basis of spontaneous mutation. I. A comparison of the deoxyribonucleic acid polymerases of mutator, antimutator, and wild type strains of bacteriophage T4. (1972) (227)
- Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector (2007) (212)
- Circulating Anti-Wild-Type Adeno-Associated Virus Type 2 (AAV2) Antibodies Inhibit Recombinant AAV2 (rAAV2)-Mediated, but Not rAAV5-Mediated, Gene Transfer in the Brain (2004) (212)
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. (2008) (204)
- The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection (1997) (200)
- Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. (2007) (193)
- Myosin IIb Regulates Actin Dynamics during Synaptic Plasticity and Memory Formation (2010) (189)
- Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization (1992) (188)
- Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus (2004) (184)
- Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. (2006) (180)
- Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein (1994) (174)
- Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4 (2006) (171)
- In vitro resolution of covalently joined AAV chromosome ends (1990) (170)
- Factors that bind to adeno-associated virus terminal repeats (1989) (166)
- Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. (1996) (164)
- High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap (1999) (160)
- Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease. (2012) (148)
- Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome (1990) (147)
- [48] Production and purification of recombinant adeno-associated virus (2000) (146)
- Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2 (2002) (145)
- In vitro replication of adeno-associated virus DNA (1994) (145)
- Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of l-dopa using rAAV-mediated gene transfer (2002) (145)
- Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9 (2012) (143)
- Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein (1993) (140)
- Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer (1999) (134)
- Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice. (1999) (132)
- In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration. (2010) (130)
- Studies on the biochemical basis of spontaneous mutation. II. The incorporation of a base and its analogue into DNA by wild-type, mutator and antimutator DNA polymerases. (1974) (128)
- In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. (2010) (127)
- Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats (1996) (125)
- OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy. (2014) (124)
- Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat (1994) (121)
- Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. (2005) (119)
- Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver (2003) (118)
- Structure and Dynamics of Adeno-Associated Virus Serotype 1 VP1-Unique N-Terminal Domain and Its Role in Capsid Trafficking (2013) (118)
- Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein (1991) (113)
- Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. (1999) (112)
- Structure of Adeno-Associated Virus Type 4 (2005) (111)
- Cellular Proteins Required for Adeno-Associated Virus DNA Replication in the Absence of Adenovirus Coinfection (1998) (110)
- Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat. (2007) (110)
- Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap (1997) (109)
- Heparin binding induces conformational changes in Adeno-associated virus serotype 2. (2009) (109)
- Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. (2002) (108)
- Production and purification of recombinant adeno-associated virus. (2000) (107)
- Mechanism of Rep-Mediated Adeno-Associated Virus Origin Nicking (2000) (99)
- Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions (2013) (97)
- Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. (2009) (97)
- Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus (1998) (96)
- Patterns of Gene Expression Reveal a Temporally Orchestrated Wound Healing Response in the Injured Spinal Cord (2004) (94)
- Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study (2001) (94)
- Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus) (2003) (93)
- Rep-Mediated Nicking of the Adeno-Associated Virus Origin Requires Two Biochemical Activities, DNA Helicase Activity and Transesterification (1999) (87)
- Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. (2005) (87)
- Biochemical Characterization of Adeno-Associated Virus Rep68 DNA Helicase and ATPase Activities (1999) (86)
- Suppression of Insult-Induced Neurogenesis in Adult Rat Brain by Brain-Derived Neurotrophic Factor (2002) (85)
- Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain (1999) (84)
- Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism. (2005) (81)
- Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafficking (2011) (80)
- Altering AAV tropism with mosaic viral capsids. (2005) (78)
- Changes in transcription within the CA1 field of the hippocampus are associated with age-related spatial learning impairments (2007) (77)
- The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter (1997) (77)
- NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats (2000) (76)
- Neuropathological and Behavioral Consequences of Adeno-Associated Viral Vector-Mediated Continuous Intrastriatal Neurotrophin Delivery in a Focal Ischemia Model in Rats (2002) (73)
- Analysis of mutations in adeno-associated virus Rep protein in vivo and in vitro (1992) (72)
- AAV: An Overview of Unanswered Questions. (2017) (71)
- Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors. (2014) (71)
- Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease. (2003) (71)
- Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma? (2015) (70)
- Identification of Cellular Proteins That Interact with the Adeno-Associated Virus Rep Protein (2008) (70)
- Complete In Vitro Reconstitution of Adeno-Associated Virus DNA Replication Requires the Minichromosome Maintenance Complex Proteins (2007) (68)
- rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease (2007) (67)
- Green fluorescent protein as a reporter for gene transfer studies in the cochlea (1997) (66)
- Cre‐mediated recombination in the pituitary gland (2000) (64)
- Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector. (2009) (63)
- Structural Insights into Adeno-Associated Virus Serotype 5 (2013) (62)
- Expression of adeno-associated virus integrated transgene within the mammalian vestibular organs. (1998) (62)
- Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. (2003) (61)
- Evidence for pH-Dependent Protease Activity in the Adeno-Associated Virus Capsid (2012) (60)
- Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. (1995) (58)
- Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice Relationship with body weight change (2000) (58)
- Genome-wide analysis of aging and learning-related genes in the hippocampal dentate gyrus (2008) (57)
- Adeno-Associated Virus Serotype 1 (AAV1)- and AAV5-Antibody Complex Structures Reveal Evolutionary Commonalities in Parvovirus Antigenic Reactivity (2014) (55)
- Adeno-Associated Virus Capsid Proteins May Play a Role in Transcription and Second-Strand Synthesis of Recombinant Genomes (2013) (54)
- Adeno-associated virus–mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo (2002) (52)
- Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 1. (2006) (51)
- The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation (1997) (51)
- Studies on the biochemical basis of spontaneous mutation. III. Rate model for DNA polymerase-effected nucleotide misincorporation. (1974) (47)
- Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors. (2002) (47)
- Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented. (2009) (46)
- In Vitro Packaging of Adeno-Associated Virus DNA (1998) (44)
- Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. (2008) (43)
- Purification of Host Cell Enzymes Involved in Adeno-Associated Virus DNA Replication (2007) (42)
- In vitro excision of adeno-associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences (1988) (40)
- Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5. (2005) (39)
- α-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. (2010) (39)
- Differential modulation of energy balance by leptin, ciliary neurotrophic factor, and leukemia inhibitory factor gene delivery: microarray deoxyribonucleic acid-chip analysis of gene expression. (2004) (39)
- Enhanced Transgene Expression from Recombinant Single-Stranded D-Sequence-Substituted Adeno-Associated Virus Vectors in Human Cell Lines In Vitro and in Murine Hepatocytes In Vivo (2014) (33)
- The genetics of adeno-associated virus. (1984) (32)
- Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging (2016) (31)
- Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9. (2009) (30)
- Gene therapy for murine mucopolysaccharidosis type VII (1997) (30)
- The Adeno-Associated Virus Genome Packaging Puzzle. (2015) (30)
- Characterization of the adenoassociated virus Rep protein complex formed on the viral origin of DNA replication. (2003) (29)
- Characterization of recombinant adeno-associated virus-2 as a vehicle for gene delivery and expression into vascular cells. (1997) (28)
- Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8. (2005) (28)
- The Effect of DNA-Dependent Protein Kinase on Adeno-Associated Virus Replication (2010) (28)
- Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 7. (2007) (27)
- Viral Expression Vectors (2011) (26)
- Mutants at the 2-Fold Interface of Adeno-associated Virus Type 2 (AAV2) Structural Proteins Suggest a Role in Viral Transcription for AAV Capsids (2016) (25)
- Adeno-associated virus (AAV) vectors: will they work? (1994) (25)
- Generation of aberrant sprouting in the adult rat brain by GAP-43 somatic gene transfer (1999) (25)
- Enhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathology (2012) (24)
- Studies of the Mechanism of Transactivation of the Adeno-Associated Virus p19 Promoter by Rep Protein (2002) (24)
- Hypothalamic rAAV-mediated GDNF gene delivery ameliorates age-related obesity (2006) (24)
- 7 Adeno-associated Viral Vectors (1999) (21)
- AAV's Golden Jubilee. (2015) (20)
- Construction of a specific amber codon in the simian virus 40 T-antigen gene by site-directed mutagenesis (1980) (19)
- An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α. (2010) (17)
- Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice. (2008) (15)
- Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid. (1998) (14)
- Purification and characterization of HeLa endonuclease R. A G-specific mammalian endonuclease. (1990) (14)
- CLONING OF AAV INTO pBR322: RESCUE OF INTACT VIRUS FROM THE RECOMBINANT PLASMID IN HUMAN CELLS (1982) (13)
- Bacteriophage T5 growth in Escherichia coli containing cloned PstI fragments of the colicin Ib plasmid (1981) (12)
- Construction of an SV40-derived cloning vector. (1980) (11)
- Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system. (2000) (11)
- Charge-to-Alanine Mutagenesis of the Adeno-Associated Virus Type 2 Rep78/68 Proteins Yields Temperature-Sensitive and Magnesium-Dependent Variants (2000) (10)
- Substrate specificity of HeLa endonuclease R. A G-specific mammalian endonuclease. (1990) (10)
- Utilization of aminopurine deoxynucleoside triphosphate by mutator, antimutator and wild-type DNA polymerases of bacteriophage T4. (1973) (9)
- Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells. (2010) (9)
- Adeno‐Associated Virus Rep78/Rep68 Promotes Localized Melting of the Rep Binding Element in the Absence of Adenosine Triphosphate (2004) (9)
- Persistence of phage lambda DNA in genomes of mouse cells transformed by lambda-carrying SV40 vectors. (1979) (7)
- Transcytosis in the blood–cerebrospinal fluid barrier of the mouse brain with an engineered receptor/ligand system (2015) (7)
- Biodistribution of Adeno-Associated Virus Type 2 with Mutations in the Capsid that Contribute to Heparan Sulfate Proteoglycan Binding. (2019) (7)
- The Lipase Activity of Phospholipase D2 is Responsible for Nigral Neurodegeneration in a Rat Model of Parkinson’s Disease (2018) (6)
- Characterization of am404, an amber mutation in the simian virus 40 T antigen gene (1983) (6)
- Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma. (2006) (5)
- Charge-to-Alanine Mutagenesis of the Adeno-Associated Virus Type 2 Rep78/68 Proteins Yields Temperature-Sensitive and Magnesium-Dependent Variants (1999) (5)
- 59. rAAV-Mediated Nigral Parkin Over-Expression Is Neuroprotective in the 6-OHDA Rat Model of Parkinson's Disease (2005) (4)
- Restriction endonuclease mapping of the colicin Ib plasmid (1982) (4)
- Manufacture and Stability of the Recombinant Adeno-Associated Virus Serotype 2 Vector Reference Standard (2008) (4)
- Construction, expression, and purification of recombinant αVβ5 integrin. (2013) (3)
- Partial Purification ofAdeno-Associated VirusRep78,Rep52,and Rep4OandTheirBiochemical Characterization (1992) (3)
- Comparison of the DNA sequence and secondary structure of the herpes simplex virus L/S junction and the adeno-associated virus terminal repeat. (1985) (3)
- Molecular cloning, overexpression, and an efficient one-step purification of α5β1 integrin. (2013) (2)
- Adeno-Associated Viral (AAV) Vectors (2010) (2)
- 400. Successful Production of Pseudotyped Mosaic rAAV Vectors Using a Modified Baculovirus Expression System (2005) (2)
- Adeno-associated virus mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo (2003) (2)
- Chapter 17:Viral Vectors for Gene Delivery (2010) (1)
- 162. Crossing the Blood-Cerebrospinal Fluid Barrier in the Mouse Choroid Plexus With an Engineered Receptor/Ligand System (2015) (1)
- recombinant AAV vectors in human cell lines in vitro and in murine hepatocytes in (2014) (1)
- Bacteriophage T5 growth in Escherichia coli containing PstI fragments of the colicin Ib plasmid. (1981) (1)
- Activation of the Unfolded Protein Response in a Rat Model of ADRP (2010) (0)
- Tailoring of the AAV capsid: designing the second generation vector (2005) (0)
- 420. Adaptation of Baculovirus System for Large-Scale Production of rAAV Vector Serotypes (2004) (0)
- 10 Adeno-associated virus-mediated knockdown of pyruvate dehydrogenase E1αα in specific regions of the rat brain (2010) (0)
- Structural Characterization of Adeno-Associated Virus Serotype 9 (2012) (0)
- ends of the AAV genome. the adeno-associated virus (AAV) rep protein to Evidence for covalent attachment of the (2013) (0)
- Structure and dynamics of Adeno-Associated Virus 1 serotype 1 VP 1-unique N-terminal domain and its role in 2 capsid trafficking (2013) (0)
- Structural insights of Adeno-Associated virus 5. A gene therapy Vector for Cystic Fibrosis (2011) (0)
- Construction of a recombinant adenoassociated virus aav vector carrying the cystic fibrosis cdna (1992) (0)
- Structure of the R432A variant of Adeno-associated virus type 2 VLP (2016) (0)
- Viral mediated retinal expression of a synthetic green fluorescent protein cDNA (1996) (0)
- a-synucleinopathy induced by recombinant AAV vector-mediated overexpression of human a-synuclein : A new primate model of Parkinson ’ s disease (2002) (0)
- Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafficking (cid:1) (2011) (0)
- 95. Incorporation of AAV Serotype 2 Viral Protein 2 into Other AAV Serotype Capsids (2016) (0)
- 1082. Transduction Comparison of AAV Serotype Vectors in the Central Nervous System (2005) (0)
- Analysis ofMutations inAdeno-Associated Virus Rep (1992) (0)
- Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides anatomical and behavioural protection against 6-OHDA lesions in the common marmoset monkey (Callithrix jacchus) (2003) (0)
- Structural Rearrangements in R432A Variant of AAV2 Affect Genome Packaging (2016) (0)
- Reversal of L-DOPA-induced dyskinesia by recombinant AAV-mediated gene transfer (2004) (0)
- Production de virions de virus adeno-associe (aav) recombinants pseudo-types (2003) (0)
- Virus Serotype 5 Structural Insights into Adeno-Associated (2014) (0)
- Adeno-associated viral mediated transfer of the Lac Z reporter gene in the optic nerve and retina of the guinea pig (1996) (0)
- AAV for disorders of the CNS (2005) (0)
- Useofadeno-associated virus asamammalian DNA cloning vector: Transduction ofneomycin resistance intomammalian (1984) (0)
- Patent Number : ( 45 ) Date of Patent : 5 , 139 , 941 Aug . 18 , 1992 ( 54 AAV TRANSDUCTION VECTORS 75 Inventors : (2017) (0)
- " Verdohemochrome IXa : Preparation and oxidoreductive cleavage to biliverdin IXa (2003) (0)
- Humanized green-fluorescent protein and methods (1997) (0)
- Structure to Function Correlations for Adeno-associated Virus Serotype 1 (2011) (0)
- Structure of Adeno-associated virus type 2 VLP (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nicholas Muzyczka?
Nicholas Muzyczka is affiliated with the following schools: